|
Pall Corporation, founded in 1946 and based in East Hills, New York, provides clients worldwide with fluid management technologies and services. The firm's library of proprietary core materials are used to address contamination, separation, purification, and detection issues. The company's filtration technology can be used to remove pathogens from blood fractions, water, and food. Systems are used to purify biotechnology drugs, reduce waste, and comply with regulatory guidelines. Pall designs, implements, and integrates filtration systems for organizations across the chemicals, medical, biopharmaceuticals, energy, microelectronics, aerospace, transportation, and government sectors. The firm provides customers with air and gas barrier filters, centrifugal devices, crossflow systems, filter assemblies and equipment, funnels, IV filters, lab water systems, luminometers, microarray slides, purifiers, small flow assemblies, syringe filters, vents, air filters, and other products. The company's Pall Acrodose PL System streamlines blood bacterial contamination testing. Pall maintains additional operations in Ireland and Puerto Rico. The firm is listed on the New York Stock Exchange under the PLL symbol. Pall was founded by physical chemist Dr. David B. Pall.
|